ICRP publication 118: ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs–threshold doses for tissue reactions in a …

FA Stewart, AV Akleyev, M Hauer-Jensen, JH Hendry… - Annals of the ICRP, 2012 - Elsevier
This report provides a review of early and late effects of radiation in normal tissues and
organs with respect to radiation protection. It was instigated following a recommendation in …

European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group …

S Krege, J Beyer, R Souchon, P Albers, W Albrecht… - European urology, 2008 - Elsevier
OBJECTIVES: The first consensus report presented by the European Germ Cell Cancer
Consensus Group (EGCCCG) in the year 2004 has found widespread approval by many …

Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008

N Donin, C Filson, A Drakaki, HJ Tan, A Castillo… - Cancer, 2016 - Wiley Online Library
BACKGROUND In the current study, the authors attempted to describe the incidence, most
common sites, and mortality of second primary malignancies among survivors of common …

Surgery in early metastatic seminoma: a phase II trial of retroperitoneal lymph node dissection for testicular seminoma with limited retroperitoneal lymphadenopathy

S Daneshmand, C Cary, T Masterson… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE The long-term toxicities of chemotherapy and radiotherapy can represent a
significant burden to testicular cancer survivors. Retroperitoneal lymph node dissection …

Relative survival in patients with chronic-phase chronic myeloid leukaemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical …

K Sasaki, SS Strom, S O'Brien, E Jabbour… - The Lancet …, 2015 - thelancet.com
Background Tyrosine-kinase inhibitors improve overall survival in patients with chronic
myeloid leukaemia in chronic phase (CML-CP). Survival compared with the general …

Second cancers among 40 576 testicular cancer patients: focus on long-term survivors

LB Travis, SD Fosså, SJ Schonfeld… - Journal of the …, 2005 - academic.oup.com
Background: Although second primary cancers are a leading cause of death among men
with testicular cancer, few studies have quantified risks among long-term survivors. Methods …

Testicular cancer in the cisplatin era: causes of death and mortality rates in a population-based cohort

R Hellesnes, TÅ Myklebust, SD Fosså… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE Using complete information regarding testicular cancer (TC) treatment burden,
this study aimed to investigate cause-specific non-TC mortality with impact on previous …

Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study

HS Haugnes, T Wethal, N Aass, O Dahl… - Journal of Clinical …, 2010 - ascopubs.org
Purpose To evaluate the prevalence of cardiovascular risk factors and long-term incidence
of cardiovascular disease (CVD) in survivors of testicular cancer (TC). Methods Overall, 990 …

Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up

HS Haugnes, GJ Bosl, H Boer, JA Gietema… - Journal of Clinical …, 2012 - ascopubs.org
Germ cell testicular cancer (TC) represents a malignancy with high cure rates. Since the
introduction of cisplatin-based chemotherapy in the late 1970s, the 5-year survival rate has …

Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 …

RTD Oliver, GM Mead, GJS Rustin, JK Joffe… - Journal of Clinical …, 2011 - ascopubs.org
Purpose Initial results of a randomized trial comparing carboplatin with radiotherapy (RT) as
adjuvant treatment for stage I seminoma found carboplatin had a noninferior relapse-free …